Genomic profile availability impact on NSCLC patient outcomes in real word study and daily practice
Thursday, June 13, 2024, 1:00 PM–2:00 PM ET
Webinar presenters Melina Marmarelis, MD, MSCE, and Salvatore Fortunato Priore, MD, PhD, will discuss a real-world study cohort utilizing electronic health records to assess the impact of the availability of genomic profiles on guiding first-line therapy and patient outcomes. They found that the availability of molecular genotyping results before first-line therapy was associated with significantly better overall survival, and that concurrent tissue and plasma testing was associated with higher odds of availability of results before first-line therapy.
Home >> REGISTER NOW
REGISTER NOW
Register for our upcoming webinar
Virtual Roundtable: Optimizing Testing for the Diagnosis of Systemic MastocytosisJune 25, 2024, 1:00 PM–2:00 PM ET
Webinar presenters Robyn Scherber, MD, MPH Hematologist UT Health SA, Medical Director Blueprint Medicines; Anton Rets, MD, PhD Associate Professor University of Utah, Medical Director Hematopathology and Immunohistochemistry; Nathan A. Boggs, MD, PhD Assistant Professor of Medicine, Uniformed Services University Allergy Division Director will discuss the barriers and possible solutions to screening for and diagnosing Systemic Mastocytosis (SM) and recommendations that will empower cross-functional laboratory stakeholders to implement changes that can help improve the diagnosis of SM. Read More »